| Field | Row 1 |
|---|---|
| adsh | 0001929980-25-000444 |
| cik | 2032950 |
| name | HORIZON SPACE ACQUISITION II CORP. |
| sic | 6770 |
| countryba | US |
| stprba | NY |
| cityba | NEW YORK |
| zipba | 10018 |
| bas1 | 1412 BROADWAY |
| bas2 | 21ST FLOOR, SUITE 21V |
| baph | (646)257-5537 |
| countryma | US |
| stprma | NY |
| cityma | NEW YORK |
| zipma | 10018 |
| mas1 | 1412 BROADWAY |
| mas2 | 21ST FLOOR, SUITE 21V |
| countryinc | KY |
| stprinc | |
| ein | 000000000 |
| former | |
| changed | |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250516 |
| accepted | 2025-05-16 15:30:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | hspt_10q_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001929980-25-000444 | 20241231 | Additional Paid In Capital | 312035.0000 | USD | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 646720.0000 | USD | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20241231 | Due To Related Party Current | 254484.0000 | USD | 0 | 0001929980-25-000444 | |||
| 0001929980-25-000444 | 20250331 | Initial Accretion Of Carrying Value To Redemption Value | 0.0000 | USD | 1 | 0001929980-25-000444 | Equity Components= Ordinary Share; | ||
| 0001929980-25-000444 | 20241231 | Liabilities And Stockholders Equity | 70064740.0000 | USD | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20240331 | Net Income Loss | -3106.0000 | USD | 1 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20240331 | Net Income Loss | -3106.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0001929980-25-000444 | 20240331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001929980-25-000444 | 20240331 | Operating Costs And Expenses | 3106.0000 | USD | 1 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20250331 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20250331 | Shares Subject To Mandatory Redemption Settlement Terms Number Of Shares | 6900000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20231231 | Stockholders Equity | -4255.0000 | USD | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20240331 | Stockholders Equity | 24827.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001929980-25-000444 | 20241231 | Stockholders Equity | 450875.0000 | USD | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20250331 | Stockholders Equity | 197396.0000 | USD | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20231231 | Stockholders Equity | 24827.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001929980-25-000444 | 20250331 | Additional Paid In Capital | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20250331 | Assets | 70559648.0000 | USD | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20250331 | Cash Equivalents At Carrying Value | 364776.0000 | USD | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20230331 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Sponsor; | ||
| 0001929980-25-000444 | 20241231 | Common Stock Shares Authorized | 490000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20250331 | Common Stock Shares Issued | 2180000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20241231 | Common Stock Shares Outstanding | 2180000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20250331 | Common Stock Shares Outstanding | 7113500.0000 | shares | 0 | us-gaap/2024 | Investment Issuer Affiliation= Right; | ||
| 0001929980-25-000444 | 20250331 | Earnings Per Share Diluted | 0.0770 | USD | 1 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20240331 | Founder Share Issued To Initial Shareholder Value | 0.0000 | USD | 1 | 0001929980-25-000444 | Equity Components= Retained Earnings; | ||
| 0001929980-25-000444 | 20250331 | Initial Accretion Of Carrying Value To Redemption Value | -312035.0000 | USD | 1 | 0001929980-25-000444 | Equity Components= Additional Paid In Capital; | ||
| 0001929980-25-000444 | 20241231 | Liabilities Current | 269335.0000 | USD | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20250331 | Net Income Loss | 472592.0000 | USD | 1 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20250331 | Net Income Loss | 472592.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0001929980-25-000444 | 20250331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Subscription Receivable; | ||
| 0001929980-25-000444 | 20250331 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20241231 | Retained Earnings Accumulated Deficit | 138622.0000 | USD | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20231231 | Shares Issued | 1725000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Ordinary Share; | ||
| 0001929980-25-000444 | 20240331 | Shares Issued | 1725000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Ordinary Share; | ||
| 0001929980-25-000444 | 20241231 | Shares Subject To Mandatory Redemption Settlement Terms Number Of Shares | 6900000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Ordinary Stocks; | ||
| 0001929980-25-000444 | 20231231 | Stockholders Equity | -25000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Subscription Receivable; | ||
| 0001929980-25-000444 | 20240331 | Stockholders Equity | -25000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Subscription Receivable; | ||
| 0001929980-25-000444 | 20250331 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001929980-25-000444 | 20250331 | Stockholders Equity | 218.0000 | USD | 0 | us-gaap/2024 | Equity Components= Ordinary Share; | ||
| 0001929980-25-000444 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding Redeemable Ordinary Shares | 0.0000 | shares | 1 | 0001929980-25-000444 | |||
| 0001929980-25-000444 | 20250331 | Assets | 70070601.0000 | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; | ||
| 0001929980-25-000444 | 20250331 | Assets Held In Trust | 70070601.0000 | USD | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20241231 | Common Stock Shares Issued | 2180000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20250331 | Common Stock Shares Outstanding | 2180000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20250331 | Common Stock Value | 218.0000 | USD | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20240331 | Increase Decrease In Prepaid Expense | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20250331 | Investment Income Interest And Dividend | 726071.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0001929980-25-000444 | 20240331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001929980-25-000444 | 20241231 | Other Accounts Payable And Accrued Liabilities | 14851.0000 | USD | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20241231 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20250331 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001929980-25-000444 | 20250331 | Stockholders Equity | -197178.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001929980-25-000444 | 20250331 | Subsequent Accretion Of Carrying Value For Public Shares To Redemption Value | 726071.0000 | USD | 1 | 0001929980-25-000444 | |||
| 0001929980-25-000444 | 20241231 | Shares Issued | 2180000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Ordinary Share; | ||
| 0001929980-25-000444 | 20241231 | Assets | 70064740.0000 | USD | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20241231 | Assets Held In Trust | 69344530.0000 | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; | ||
| 0001929980-25-000444 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | Class Of Stock= Ordinary Stocks; | ||
| 0001929980-25-000444 | 20241231 | Common Stock Per Share | 10.0500 | USD | 0 | 0001929980-25-000444 | Class Of Stock= Ordinary Stocks; | ||
| 0001929980-25-000444 | 20250331 | Common Stock Shares Authorized | 490000000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Ordinary Stocks; | ||
| 0001929980-25-000444 | 20240331 | Earnings Per Share Diluted | 0.0000 | USD | 1 | us-gaap/2024 | Class Of Stock= Redeemable Ordinary Stock; | ||
| 0001929980-25-000444 | 20250331 | Earnings Per Share Diluted | 0.0770 | USD | 1 | us-gaap/2024 | Class Of Stock= Redeemable Ordinary Stock; | ||
| 0001929980-25-000444 | 20250331 | Investment Income Interest And Dividend | 726071.0000 | USD | 1 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20250331 | Liabilities | 291651.0000 | USD | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20250331 | Liabilities Current | 291651.0000 | USD | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20240331 | Net Cash Provided By Used In Operating Activities | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20250331 | Net Cash Provided By Used In Operating Activities | -281944.0000 | USD | 1 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20250331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001929980-25-000444 | 20250331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Ordinary Share; | ||
| 0001929980-25-000444 | 20250331 | Preferred Stock Shares Authorized | 10000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20241231 | Shares Subject To Mandatory Redemption Settlement Terms Amount | 69344530.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Ordinary Stocks; | ||
| 0001929980-25-000444 | 20231231 | Stockholders Equity | -4255.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001929980-25-000444 | 20250331 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Subscription Receivable; | ||
| 0001929980-25-000444 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20250331 | Assets Current | 489047.0000 | USD | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20250331 | Assets Held In Trust | 70070601.0000 | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; | ||
| 0001929980-25-000444 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20241231 | Common Stock Value | 218.0000 | USD | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20240331 | Founder Share Issued To Initial Shareholder Value | 0.0000 | USD | 1 | 0001929980-25-000444 | |||
| 0001929980-25-000444 | 20240331 | Founder Share Issued To Initial Shareholder Value | 0.0000 | USD | 1 | 0001929980-25-000444 | Equity Components= Additional Paid In Capital; | ||
| 0001929980-25-000444 | 20240331 | Founder Share Issued To Initial Shareholder Value | 0.0000 | USD | 1 | 0001929980-25-000444 | Equity Components= Ordinary Share; | ||
| 0001929980-25-000444 | 20250331 | Initial Accretion Of Carrying Value To Redemption Value | 0.0000 | USD | 1 | 0001929980-25-000444 | Equity Components= Preferred Stock; | ||
| 0001929980-25-000444 | 20250331 | Initial Accretion Of Carrying Value To Redemption Value | -414036.0000 | USD | 1 | 0001929980-25-000444 | Equity Components= Retained Earnings; | ||
| 0001929980-25-000444 | 20240331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Subscription Receivable; | ||
| 0001929980-25-000444 | 20240331 | Operating Costs And Expenses | 3106.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0001929980-25-000444 | 20250331 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20241231 | Prepaid Expense Current | 73490.0000 | USD | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20250331 | Prepaid Expense Current | 124271.0000 | USD | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20250331 | Shares Subject To Mandatory Redemption Settlement Terms Amount | 70070601.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Ordinary Stocks; | ||
| 0001929980-25-000444 | 20241231 | Stockholders Equity | 138622.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001929980-25-000444 | 20240331 | Weighted Average Basic Shares Outstanding Pro Forma Non Redeemable Ordinary Shares | 1725000.0000 | shares | 1 | 0001929980-25-000444 | |||
| 0001929980-25-000444 | 20250331 | Weighted Average Basic Shares Outstanding Pro Forma Non Redeemable Ordinary Shares | 2180000.0000 | shares | 1 | 0001929980-25-000444 | |||
| 0001929980-25-000444 | 20241231 | Assets | 69344530.0000 | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; | ||
| 0001929980-25-000444 | 20241231 | Assets Current | 720210.0000 | USD | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20241231 | Assets Held In Trust | 69344530.0000 | USD | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 364776.0000 | USD | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20241231 | Common Stock Shares Outstanding | 6900000.0000 | shares | 0 | us-gaap/2024 | Investment Issuer Affiliation= Right; | ||
| 0001929980-25-000444 | 20250331 | Due To Related Party Current | 254484.0000 | USD | 0 | 0001929980-25-000444 | |||
| 0001929980-25-000444 | 20240331 | Earnings Per Share Diluted Non Redeemable Ordinary Shares | -0.0020 | USD | 1 | 0001929980-25-000444 | |||
| 0001929980-25-000444 | 20250331 | Income Loss From Continuing Operations | -253479.0000 | USD | 1 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20250331 | Initial Accretion Of Carrying Value To Redemption Value | 0.0000 | USD | 1 | 0001929980-25-000444 | Equity Components= Subscription Receivable; | ||
| 0001929980-25-000444 | 20241231 | Liabilities | 269335.0000 | USD | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20250331 | Liabilities And Stockholders Equity | 70559648.0000 | USD | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20250331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001929980-25-000444 | 20241231 | Preferred Stock Shares Authorized | 10000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20241231 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20241231 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20240331 | Profit Loss | -3106.0000 | USD | 1 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20250331 | Retained Earnings Accumulated Deficit | 197178.0000 | USD | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20250331 | Shares Subject To Mandatory Redemption Settlement Terms Number Of Shares | 6900000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Ordinary Stocks; | ||
| 0001929980-25-000444 | 20231231 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001929980-25-000444 | 20240331 | Stockholders Equity | 173.0000 | USD | 0 | us-gaap/2024 | Equity Components= Ordinary Share; | ||
| 0001929980-25-000444 | 20240331 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001929980-25-000444 | 20240331 | Stockholders Equity | -7361.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001929980-25-000444 | 20241231 | Stockholders Equity | 218.0000 | USD | 0 | us-gaap/2024 | Equity Components= Ordinary Share; | ||
| 0001929980-25-000444 | 20240331 | Subsequent Accretion Of Carrying Value For Public Shares To Redemption Value | 0.0000 | USD | 1 | 0001929980-25-000444 | |||
| 0001929980-25-000444 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -281944.0000 | USD | 1 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20241231 | Cash Equivalents At Carrying Value | 646720.0000 | USD | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | Class Of Stock= Ordinary Stocks; | ||
| 0001929980-25-000444 | 20241231 | Common Stock Shares Authorized | 490000000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Ordinary Stocks; | ||
| 0001929980-25-000444 | 20240331 | Earnings Per Share Diluted | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20250331 | Earnings Per Share Diluted | -0.0280 | USD | 1 | us-gaap/2024 | Class Of Stock= Non Redeemable Ordinary Stock; | ||
| 0001929980-25-000444 | 20250331 | Earnings Per Share Diluted Non Redeemable Ordinary Shares | -0.0280 | USD | 1 | 0001929980-25-000444 | |||
| 0001929980-25-000444 | 20240331 | Founder Share Issued To Initial Shareholder Value | 0.0000 | USD | 1 | 0001929980-25-000444 | Equity Components= Preferred Stock; | ||
| 0001929980-25-000444 | 20240331 | Increase Decrease In Accrued Liabilities | 3106.0000 | USD | 1 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20250331 | Increase Decrease In Accrued Liabilities | 22316.0000 | USD | 1 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20250331 | Initial Accretion Of Carrying Value To Redemption Value | -726071.0000 | USD | 1 | 0001929980-25-000444 | |||
| 0001929980-25-000444 | 20240331 | Investment Income Interest And Dividend | 0.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0001929980-25-000444 | 20240331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Ordinary Share; | ||
| 0001929980-25-000444 | 20250331 | Operating Costs And Expenses | 253479.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0001929980-25-000444 | 20250331 | Other Accounts Payable And Accrued Liabilities | 37167.0000 | USD | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20250331 | Shares Issued | 2180000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Ordinary Share; | ||
| 0001929980-25-000444 | 20241231 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Subscription Receivable; | ||
| 0001929980-25-000444 | 20240331 | Income Loss From Continuing Operations | -3106.0000 | USD | 1 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20250430 | Common Stock Par Or Stated Value Per Share | 1.0000 | USD | 0 | us-gaap/2024 | Subsequent Event Type= Subsequent Event; | ||
| 0001929980-25-000444 | 20250331 | Common Stock Per Share | 10.1600 | USD | 0 | 0001929980-25-000444 | Class Of Stock= Ordinary Stocks; | ||
| 0001929980-25-000444 | 20250331 | Common Stock Shares Authorized | 490000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20240331 | Earnings Per Share Diluted | -0.0020 | USD | 1 | us-gaap/2024 | Class Of Stock= Non Redeemable Ordinary Stock; | ||
| 0001929980-25-000444 | 20240331 | Founder Share Issued To Initial Shareholder Value | 0.0000 | USD | 1 | 0001929980-25-000444 | Equity Components= Subscription Receivable; | ||
| 0001929980-25-000444 | 20240331 | Net Income Loss | -3106.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001929980-25-000444 | 20250331 | Net Income Loss | 472592.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001929980-25-000444 | 20250331 | Operating Costs And Expenses | 253479.0000 | USD | 1 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20250331 | Profit Loss | 472592.0000 | USD | 1 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20231231 | Stockholders Equity | 173.0000 | USD | 0 | us-gaap/2024 | Equity Components= Ordinary Share; | ||
| 0001929980-25-000444 | 20240331 | Stockholders Equity | -7361.0000 | USD | 0 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20241231 | Stockholders Equity | 312035.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001929980-25-000444 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding Redeemable Ordinary Shares | 6900000.0000 | shares | 1 | 0001929980-25-000444 | |||
| 0001929980-25-000444 | 20250331 | Increase Decrease In Prepaid Expense | 50781.0000 | USD | 1 | us-gaap/2024 | |||
| 0001929980-25-000444 | 20240331 | Investment Income Interest And Dividend | 0.0000 | USD | 1 | us-gaap/2024 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Investment Income Interest And Dividend | us-gaap/2024 | 0 | 0 | monetary | D | C | Investment Income, Interest and Dividend | Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Common Stock Per Share | 0001929980-25-000444 | 1 | 0 | perShare | I | Ordinary shares, Per shares | ||
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Prepaid Expense Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Earnings Per Share Diluted Non Redeemable Ordinary Shares | 0001929980-25-000444 | 1 | 0 | perShare | D | Basic and diluted net loss per share, non-redeemable ordinary shares | ||
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Increase Decrease In Prepaid Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense | The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods. |
| Other Accounts Payable And Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Other Accounts Payable and Accrued Liabilities | Amount of liabilities incurred and payable to vendors for goods and services received classified as other, and expenses incurred but not yet paid, payable within one year or the operating cycle, if longer. |
| Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Shares, Issued | Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. | |
| Shares Subject To Mandatory Redemption Settlement Terms Number Of Shares | us-gaap/2024 | 0 | 0 | shares | I | Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Number of Shares | The number of shares that would be issued, determined under the conditions specified in the contract, if the settlement were to occur at the reporting date. | |
| Due To Related Party Current | 0001929980-25-000444 | 1 | 0 | monetary | I | C | Amount due to related party | |
| Weighted Average Basic Shares Outstanding Pro Forma Non Redeemable Ordinary Shares | 0001929980-25-000444 | 1 | 0 | shares | D | Weighted average shares outstanding of non-redeemable ordinary shares | ||
| Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash Equivalents, at Carrying Value | Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Preferred Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
| Preferred Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Profit Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Initial Accretion Of Carrying Value To Redemption Value | 0001929980-25-000444 | 1 | 0 | monetary | D | C | Accretion of carrying value to redemption value | |
| Shares Subject To Mandatory Redemption Settlement Terms Amount | us-gaap/2024 | 0 | 0 | monetary | I | C | Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount | Amount that would be paid, determined under the conditions specified in the contract, if the holder of the share has the right to redeem the shares. |
| Founder Share Issued To Initial Shareholder Value | 0001929980-25-000444 | 1 | 0 | monetary | D | C | Founder share issued to initial shareholder | |
| Weighted Average Number Of Diluted Shares Outstanding Redeemable Ordinary Shares | 0001929980-25-000444 | 1 | 0 | shares | D | Weighted average shares outstanding of redeemable ordinary shares | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Income Loss From Continuing Operations | us-gaap/2024 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | Amount after tax of income (loss) from continuing operations attributable to the parent. |
| Operating Costs And Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Costs and Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense. |
| Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
| Assets Held In Trust | us-gaap/2024 | 0 | 0 | monetary | I | D | Asset, Held-in-Trust | The total amount of cash and securities held by third party trustees pursuant to terms of debt instruments or other agreements as of the date of each statement of financial position presented, which can be used by the trustee only to pay the noncurrent portion of specified obligations. |
| Preferred Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Preferred Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
| Subsequent Accretion Of Carrying Value For Public Shares To Redemption Value | 0001929980-25-000444 | 1 | 0 | monetary | D | C | Subsequent accretion of carrying value for public shares to redemption value | |
| Increase Decrease In Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accrued Liabilities | The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001929980-25-000444 | 2 | 6 | BS | 0 | H | Cash Equivalents At Carrying Value | us-gaap/2024 | Cash | 0 |
| 0001929980-25-000444 | 2 | 7 | BS | 0 | H | Prepaid Expense Current | us-gaap/2024 | Prepaid expense | 0 |
| 0001929980-25-000444 | 2 | 8 | BS | 0 | H | Assets Current | us-gaap/2024 | Total Current Assets | 0 |
| 0001929980-25-000444 | 2 | 9 | BS | 0 | H | Assets Held In Trust | us-gaap/2024 | Investment held in Trust Account | 0 |
| 0001929980-25-000444 | 2 | 10 | BS | 0 | H | Assets | us-gaap/2024 | Total Assets | 0 |
| 0001929980-25-000444 | 2 | 12 | BS | 0 | H | Due To Related Party Current | 0001929980-25-000444 | Amount due to related party | 0 |
| 0001929980-25-000444 | 2 | 13 | BS | 0 | H | Other Accounts Payable And Accrued Liabilities | us-gaap/2024 | Other payable and accrued expenses | 0 |
| 0001929980-25-000444 | 2 | 14 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total Current Liabilities | 0 |
| 0001929980-25-000444 | 2 | 15 | BS | 0 | H | Liabilities | us-gaap/2024 | Total Liabilities | 0 |
| 0001929980-25-000444 | 2 | 16 | BS | 0 | H | Shares Subject To Mandatory Redemption Settlement Terms Amount | us-gaap/2024 | Ordinary shares, $0.0001 par value, 490,000,000 shares authorized, 6,900,000 shares subject to possible redemption at $10.16 $10.05 per share as of March 31, 2025 and December 31, 2024, respectively. | 0 |
| 0001929980-25-000444 | 2 | 17 | BS | 0 | H | Preferred Stock Value | us-gaap/2024 | Preferred share, $0.0001 par value, 10,000,000 shares authorized, none issued and outstanding | 0 |
| 0001929980-25-000444 | 2 | 18 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Ordinary shares, $0.0001 par value, 490,000,000 shares authorized, 6,900,000 shares subject to possible redemption at $10.16 and $10.05 per share as of March 31, 2025 and December 31, 2024, respectively. | 0 |
| 0001929980-25-000444 | 2 | 19 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in capital | 0 |
| 0001929980-25-000444 | 2 | 20 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Retained earnings | 0 |
| 0001929980-25-000444 | 2 | 21 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total Shareholders' Equity (Deficit) | 0 |
| 0001929980-25-000444 | 2 | 22 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total Liabilities, Ordinary Shares Subject to Possible Redemption and Shareholders' Equity (Deficit) | 0 |
| 0001929980-25-000444 | 3 | 6 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | Preferred share par value | 0 |
| 0001929980-25-000444 | 3 | 7 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2024 | Preferred share, shares authorized | 0 |
| 0001929980-25-000444 | 3 | 8 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2024 | Preferred share, shares issued | 0 |
| 0001929980-25-000444 | 3 | 9 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2024 | Preferred share, shares outstanding | 0 |
| 0001929980-25-000444 | 3 | 10 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Ordinary shares, Par value | 0 |
| 0001929980-25-000444 | 3 | 11 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Ordinary shares, shares authorized | 0 |
| 0001929980-25-000444 | 3 | 12 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Ordinary shares, shares issued | 0 |
| 0001929980-25-000444 | 3 | 13 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Ordinary shares, shares outstanding | 0 |
| 0001929980-25-000444 | 3 | 14 | BS | 1 | H | Shares Subject To Mandatory Redemption Settlement Terms Number Of Shares | us-gaap/2024 | Ordinary shares subject to possible redemption | 0 |
| 0001929980-25-000444 | 3 | 15 | BS | 1 | H | Common Stock Per Share | 0001929980-25-000444 | Ordinary shares, Per shares | 0 |
| 0001929980-25-000444 | 4 | 1 | IS | 0 | H | Operating Costs And Expenses | us-gaap/2024 | Formation and operating costs | 0 |
| 0001929980-25-000444 | 4 | 2 | IS | 0 | H | Income Loss From Continuing Operations | us-gaap/2024 | Loss from operations | 0 |
| 0001929980-25-000444 | 4 | 4 | IS | 0 | H | Investment Income Interest And Dividend | us-gaap/2024 | Interest and dividend income on investments held in Trust | 0 |
| 0001929980-25-000444 | 4 | 5 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net Income (Loss) | 0 |
| 0001929980-25-000444 | 4 | 6 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding Redeemable Ordinary Shares | 0001929980-25-000444 | Weighted average shares outstanding of redeemable ordinary shares | 0 |
| 0001929980-25-000444 | 4 | 7 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Basic and diluted net income per share, ordinary shares | 0 |
| 0001929980-25-000444 | 4 | 8 | IS | 0 | H | Weighted Average Basic Shares Outstanding Pro Forma Non Redeemable Ordinary Shares | 0001929980-25-000444 | Weighted average shares outstanding of non-redeemable ordinary shares | 0 |
| 0001929980-25-000444 | 4 | 9 | IS | 0 | H | Earnings Per Share Diluted Non Redeemable Ordinary Shares | 0001929980-25-000444 | Basic and diluted net loss per share, non-redeemable ordinary shares | 0 |
| 0001929980-25-000444 | 5 | 10 | EQ | 0 | H | Shares Issued | us-gaap/2024 | Balance, shares | 0 |
| 0001929980-25-000444 | 5 | 11 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance, amount | 0 |
| 0001929980-25-000444 | 5 | 12 | EQ | 0 | H | Founder Share Issued To Initial Shareholder Value | 0001929980-25-000444 | Founder share issued to initial shareholder | 0 |
| 0001929980-25-000444 | 5 | 13 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001929980-25-000444 | 5 | 14 | EQ | 0 | H | Initial Accretion Of Carrying Value To Redemption Value | 0001929980-25-000444 | Accretion of carrying value to redemption value | 0 |
| 0001929980-25-000444 | 5 | 15 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance, amount | 0 |
| 0001929980-25-000444 | 5 | 16 | EQ | 0 | H | Shares Issued | us-gaap/2024 | Balance, shares | 0 |
| 0001929980-25-000444 | 6 | 2 | CF | 0 | H | Profit Loss | us-gaap/2024 | Net loss | 0 |
| 0001929980-25-000444 | 6 | 4 | CF | 0 | H | Investment Income Interest And Dividend | us-gaap/2024 | Dividend and interest income on Trust Account | 1 |
| 0001929980-25-000444 | 6 | 6 | CF | 0 | H | Increase Decrease In Prepaid Expense | us-gaap/2024 | Prepaid expense | 1 |
| 0001929980-25-000444 | 6 | 7 | CF | 0 | H | Increase Decrease In Accrued Liabilities | us-gaap/2024 | Accrued expense | 0 |
| 0001929980-25-000444 | 6 | 8 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net Cash Provided By Operating Activities | 0 |
| 0001929980-25-000444 | 6 | 9 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | Net Change in Cash | 0 |
| 0001929980-25-000444 | 6 | 10 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash, beginning of the year | 0 |
| 0001929980-25-000444 | 6 | 11 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash, end of the period | 0 |
| 0001929980-25-000444 | 6 | 13 | CF | 0 | H | Subsequent Accretion Of Carrying Value For Public Shares To Redemption Value | 0001929980-25-000444 | Subsequent accretion of carrying value for public shares to redemption value | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |